Clinical trial
Sex and Disease Dependent Nucleoside Analog Toxicity
NCT01386970 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sex and Disease Dependent Nucleoside Analog Toxicity
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2005
- Completion date
- July 31, 2010
- Enrollment
- 43 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv